ClinicalTrials.Veeva

Menu

Effect of Quercetin in Prevention and Treatment of Oral Mucositis

M

Mashhad University of Medical Sciences

Status and phase

Completed
Phase 2
Phase 1

Conditions

Chemotherapy Induced Oral Mucositis

Treatments

Drug: Placebo
Drug: oral quercetin capsules

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The study aims to evaluate the effect of Quercetin (a natural flavonoid) on prevention of and treatment of chemotherapy-induced oral mucositis in patients with blood malignancies.

Enrollment

20 patients

Sex

All

Ages

15 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient under chemotherapy
  • for a hematologic malignancy
  • the hematologist permits the trial on the patient
  • agreement of patient for participating in the trial

Exclusion criteria

  • presence pf ANY oral lesion at the beginning of the trial
  • loss of follow up
  • use of digoxin and cyclosporine
  • patient death

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

20 participants in 2 patient groups, including a placebo group

oral quercetin capsules
Active Comparator group
Description:
Patients in the intervention group were administered two, 250 mg Quercetin capsules daily for 3 weeks
Treatment:
Drug: oral quercetin capsules
oral placebo capsules
Placebo Comparator group
Description:
Patients in the placebo group received two placebo capsules containing lactose .
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems